MedTrace Logo

Hyperbaric Oxygen Therapy Registry

NCT02483650 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2018-05-01

No results posted yet for this study

Summary

The purpose of the Hyperbaric Oxygen Therapy Registry (HBOTR) is to provide real world patient outcome and side effect information from electronic health records submitted to a specialty specific hyperbaric registry as part of "Stage 2 of Meaningful Use," including data provided to meet PQRS requirements via the registry's QCDR mission.

Goals include understanding the value of HBOT among patients treated for a variety of conditions in relation to the frequency and severity of HBOT side effects. While randomized, controlled trials can establish the efficacy of treatments like HBOT, because they routinely exclude patients with co-morbid conditions common to those patients seen in usual clinical practice, the results of RCTs are usually non-generalizable. Real world data can be used to better understand the effectiveness of HBOT among typical patients, as well as the risks associated with treatment.

Conditions

  • Air or Gas Embolism
  • Carbon Monoxide Poisoning
  • Clostridial Myositis and Myonecrosis (Gas Gangrene)
  • Crush Injury, Compartment Syndrome & Other Acute Traumatic Ischemias
  • Decompression Sickness
  • Peripheral Arterial Insufficiency and Central Retinal Artery Occlusion
  • Severe Anemia
  • Intracranial Abscess
  • Necrotizing Soft Tissue Infections
  • Osteomyelitis (Refractory)
  • Delayed Radiation Injury (Soft Tissue and Bony Necrosis)
  • Compromised Grafts and Flaps
  • Acute Thermal Burn Injury
  • Idiopathic Sudden Sensorineural Hearing Loss

Sponsors & Collaborators

  • Undersea and Hyperbaric Medical Society (UHMS)

    collaborator UNKNOWN

  • U.S. Wound Registry

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2020-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02483650 on ClinicalTrials.gov